PIVAC 2018 was held in Oslo, co-organized by the department of Cell Therpay. The conference permitted to share new advance in the field of vaccination and future prospects for immunotherapy.
Moreno-Sanchez PM, Rezaeipour M, Inderberg EM, Platten M, Golebiewska A (2026) Immunosuppressive mechanisms and therapeutic interventions shaping glioblastoma immunity Nat Cancer (in press) DOI 10.1038/s43018-025-01097-9, PubMed 41507535 Abrantes R, Forcados C, Warren DJ, Santos-Ferreira L, Fleten KG, Senra E, Costa AF, Krpina K, Henrique R, Liberg AM, Rawat P, Gelebart P, McCormack E, Bjørge L, Davidson B, Greiff V, Costea DE, Pinto F, Flatmark K, Gomes C, Inderberg EM, Reis CA, Wälchli S (2025) Pan-carcinoma sialyl-Tn-targeting expands CAR therapy to solid tumors Cell Rep Med, 6 (9), 102350 DOI 10.1016/j.xcrm.2025.102350, PubMed 40925376 Sæbøe-Larssen S, Sioud M (2025) Enhancing Cancer Vaccine Efficacy: siRNA-Based Modulation of Immune Suppressive Factors in Dendritic Cells Methods Mol Biol, 2965, 259-273 DOI 10.1007/978-1-0716-4742-4_12, PubMed 40877509 More publications
